Cargando…

Correction: Genetic and clinical characteristics in Japanese hereditary breast and ovarian cancer: first report after establishment of HBOC registration system in Japan

Detalles Bibliográficos
Autores principales:	Arai, Masami, Yokoyama, Shiro, Watanabe, Chie, Yoshida, Reiko, Kita, Mizuho, Okawa, Megumi, Sakurai, Akihiro, Sekine, Masayuki, Yotsumoto, Junko, Nomura, Hiroyuki, Akama, Yoshinori, Inuzuka, Mayuko, Nomizu, Tadashi, Enomoto, Takayuki, Nakamura, Seigo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119227/ https://www.ncbi.nlm.nih.gov/pubmed/29386572 http://dx.doi.org/10.1038/s10038-017-0395-6

Ejemplares similares

Genetic and clinical characteristics in Japanese hereditary breast and ovarian cancer: first report after establishment of HBOC registration system in Japan
por: Arai, Masami, et al.
Publicado: (2017)

Analysis of clinical characteristics of breast cancer patients with the Japanese founder mutation BRCA1 L63X
por: Yoshida, Reiko, et al.
Publicado: (2019)

High rate of occult cancer found in prophylactic mastectomy specimens despite thorough presurgical assessment with MRI and ultrasound: findings from the Hereditary Breast and Ovarian Cancer Registration 2016 in Japan
por: Yamauchi, Hideko, et al.
Publicado: (2018)

Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis
por: Yoshida, Reiko
Publicado: (2020)

Prevalence of hereditary breast and ovarian cancer (HBOC) predisposition gene mutations among 882 HBOC high‐risk Chinese individuals
por: Shao, Di, et al.
Publicado: (2019)

The disease sites of female genital cancers of BRCA1/2-associated hereditary breast and ovarian cancer: a retrospective study
por: Mitamura, Takashi, et al.
Publicado: (2021)

Editorial: HBOC and high-risk screening: up-to-date
por: Kataoka, Masako
Publicado: (2021)

Prevalence of disease-causing genes in Japanese patients with BRCA1/2-wildtype hereditary breast and ovarian cancer syndrome
por: Kaneyasu, Tomoko, et al.
Publicado: (2020)

Differences in age at diagnosis of ovarian cancer for each BRCA mutation type in Japan: optimal timing to carry out risk-reducing salpingo-oophorectomy
por: Sekine, Masayuki, et al.
Publicado: (2022)

Somatic BRCA Mutation in a Cholangiocarcinoma Patient for HBOC Syndrome Detection
por: Paradiso, Angelo Virgilio, et al.
Publicado: (2020)

New Applications of HBOC-201: A 25-Year Review of the Literature
por: Cao, Min, et al.
Publicado: (2021)

Comparative In Vivo Effects of Hemoglobin-Based Oxygen Carriers (HBOC) with Varying Prooxidant and Physiological Reactivity
por: Toma, Vlad Al., et al.
Publicado: (2016)

The efficacy of HBOC‐201 in ex situ gradual rewarming kidney perfusion in a rat model
por: Mahboub, Paria, et al.
Publicado: (2019)

HBOC-301 in Porcine Kidney Normothermic Machine Perfusion and the Effect of Vitamin C on Methemoglobin Formation
por: Edgworth, Eileen, et al.
Publicado: (2022)

Silk Fibroin Particles as Carriers in the Development of All-Natural Hemoglobin-Based Oxygen Carriers (HBOCs)
por: Pacheco, Marisa O, et al.
Publicado: (2023)

Characteristics of BRCA1/2 pathogenic germline mutations in chinese NSCLC patients and a comparison with HBOC
por: Xu, Zheyuan, et al.
Publicado: (2021)

Diagnostic yield and clinical relevance of expanded germline genetic testing for nearly 7000 suspected HBOC patients
por: Henkel, Jan, et al.
Publicado: (2023)

Screening of BRCA1/2 genes mutations and copy number variations in patients with high risk for hereditary breast and ovarian cancer syndrome (HBOC)
por: El Ansari, Fatima Zahra, et al.
Publicado: (2020)

Mutation screening of BRCA1, BRCA2 and CHEK2*1100delC in Slovak HBOC families
por: Cierniková, S, et al.
Publicado: (2005)

Cancer predisposition genes: molecular mechanisms and clinical impact on personalized cancer care: examples of Lynch and HBOC syndromes
por: Wang, Qing
Publicado: (2016)

Genetic Counseling, Testing, and Management of HBOC in India: An Expert Consensus Document from Indian Society of Medical and Pediatric Oncology
por: Malhotra, Hemant, et al.
Publicado: (2020)

2: Ex-vivo Normothermic Preservation Of Amputated Limbs With A Hemoglobin-based Oxygen Carrier (HBOC-201) Perfusate
por: Figueroa, Brian A., et al.
Publicado: (2021)

Pre-counseling Education for Low Literacy Women at Risk of Hereditary Breast and Ovarian Cancer (HBOC): Patient Experiences Using the Cancer Risk Education Intervention Tool (CREdIT)
por: Joseph, Galen, et al.
Publicado: (2010)

Application of the bovine hemoglobin solution HBOC-301 with and without isovolemic hemodilution reduces the histopathologic damage in acute severe pancreatitis in swine
por: Freitag, M, et al.
Publicado: (2005)

Abstract 49: Outcomes Of Ex-vivo Normothermic Limb Perfusion (EVNLP) With A Hemoglobin-based Oxygen Carrier (HBOC-201)
por: Orfahli, Lynn M., et al.
Publicado: (2020)

BRCA1 and BRCA2 mutational profile and prevalence in hereditary breast and ovarian cancer (HBOC) probands from Southern Brazil: Are international testing criteria appropriate for this specific population?
por: Alemar, Bárbara, et al.
Publicado: (2017)

Management of thymoma‐associated pure red cell aplasia: A novel use of blood substitute HBOC‐201 in a Jehovah’s Witness
por: Rubinstein, Maria M., et al.
Publicado: (2019)

Correction: BRCA1 and BRCA2 mutational profile and prevalence in hereditary breast and ovarian cancer (HBOC) probands from Southern Brazil: Are international testing criteria appropriate for this specific population?
por: Alemar, Bárbara, et al.
Publicado: (2018)

Eating disorders among patients incarcerated only for repeated shoplifting: a retrospective quasi-case-control study in a medical prison in Japan
por: Asami, Tomokuni, et al.
Publicado: (2014)

Mutation status of RAD51C,PALB2 and BRIP1 in 100 Japanese familial breast cancer cases without BRCA1 and BRCA2 mutations
por: Sato, Katsutoshi, et al.
Publicado: (2017)

Germline mutations in BRCA1, BRCA2, CHEK2 and TP53 in patients at high-risk for HBOC: characterizing a Northeast Brazilian Population
por: Felix, Gabriela ES, et al.
Publicado: (2014)

Familial history and prevalence of BRCA1, BRCA2 and TP53 pathogenic variants in HBOC Brazilian patients from a public healthcare service
por: Matta, Bruna Palma, et al.
Publicado: (2022)

HBOC syndrome with an uncharacterized variant in the BRCA1 gene in a patient diagnosed with endometrial cancer after surgery for bilateral breast cancer: A case report
por: Mabuchi, Yasushi, et al.
Publicado: (2022)

BRCA Genetic Test and Risk-Reducing Salpingo-Oophorectomy for Hereditary Breast and Ovarian Cancer: State-of-the-Art
por: Sekine, Masayuki, et al.
Publicado: (2021)

Draft Genome Sequence of Violacein-Producing Marine Bacterium Pseudoalteromonas sp. 520P1
por: Dang, Hoang Tran, et al.
Publicado: (2014)

Abstract: 8.30 Subnormothermic Machine Perfusion (Snmp) With A Novel Hemoglobin-Based Oxygen Carrier (Hboc) Solution For Ex Vivo Preservation In Vascularized Composite Allotransplantation (Vca)
por: Schweizer, Riccardo, et al.
Publicado: (2017)

Registration error of the liver CT using deformable image registration of MIM Maestro and Velocity AI
por: Fukumitsu, Nobuyoshi, et al.
Publicado: (2017)

An Anti-Human Lutheran Glycoprotein Phage Antibody Inhibits Cell Migration on Laminin-511: Epitope Mapping of the Antibody
por: Enomoto-Okawa, Yurie, et al.
Publicado: (2017)

The clinical impact of MRI screening for BRCA mutation carriers: the first report in Japan
por: Murakami, Wakana, et al.
Publicado: (2019)

Five screening-detected breast cancer cases in initially disease-free BRCA1 or BRCA2 mutation carriers
por: Shimada, Satoko, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_a82pfjbclcd946qmrl54gk2jqt